demonstrated that both systemic genetic elimination and inhibition with vildagliptin reversed interstitial fibrosis and decreased Ctgf mRNA levels caused by streptozotocin‐induced diabetes after TAC surgery in male Fischer 344 rats. This evidence concerns the gene CCN2 and diabetes mellitus.